Clinical Trial: Multicenter study on the real-world use of an automated pegfilgrastim delivery device and its impact on patient burden, including time and financial toxicity, in Japan (Japan)

Tokyo, Sept. 5 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062774) titled 'Study of an automated pegfilgrastim delivery device and its impact on time and financial burden in patients receiving chemotherapy' on Sept. 5.

Study Type: Observational

Primary Sponsor: Institute - Showa Medical University Yokohama Northern Hospital

Condition: Condition - Breast cancer Classification by malignancy - Malignancy Genomic information - NO

Objective: Narrative objectives1 - The aim of this study is to characterize the real-world use of an automated pegfilgrastim delivery device (BodyPod) in Japan and to quantitatively evaluate its convenience from the perspectives of time toxicity and financial toxic...